Advances in Clinical Chemistry
- 1st Edition, Volume 102 - May 24, 2021
- Editor: Gregory S. Makowski
- Language: English
- Hardback ISBN:9 7 8 - 0 - 1 2 - 8 2 4 6 1 4 - 6
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 8 5 0 9 9 - 5
Advances in Clinical Chemistry, Volume 102, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scient… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quote- Provides the most up-to-date technologies in clinical chemistry and clinical laboratory science
- Authored by world-renowned clinical laboratory scientists, physicians and research scientists
- Presents the international benchmark for novel analytical approaches in the clinical laboratory
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Preface
- Chapter One: Advances in immunosensor technology
- Abstract
- 1: Introduction
- 2: Classification of immunosensors based on their transducers
- 3: Conclusion and future perspectives
- Chapter Two: Extracellular vesicles: Roles and applications in drug-induced liver injury
- Abstract
- 1: Introduction
- 2: Extracellular vesicle nomenclature
- 3: Extracellular vesicle biogenesis
- 4: EV targeting and uptake
- 5: Drug-induced liver injury
- 6: Extracellular vesicle biomarkers in DILI
- 7: Extracellular vesicles: Potential applications in DILI
- 8: Conclusion and future perspectives
- Acknowledgments
- Conflict of interest
- Chapter Three: Oxidative stress biomarkers in the preterm infant
- Abstract
- 1: Introduction
- 2: Biomarkers and methods for the assessment of OS
- 3: Perinatal events promoting a pro-oxidant status in preterm infants
- 4: Interventions aiming at the reduction of OS in preterm infants
- 5: Pathologies of preterm infants associated to OS
- 6: Conclusions and future applications
- Chapter Four: Translational biomarkers in the era of precision medicine
- Abstract
- 1: Introduction and background
- 2: Biomarkers and translational medicine
- 3: Precision medicine
- 4: Technologies-omics
- 5: Methodological advancement
- 6: Summary and discussion
- Acknowledgments
- Chapter Five: Metabolomics applications in coronary artery disease personalized medicine
- Abstract
- 1: Introduction
- 2: Systems' biology or “Omics” disciplines and personalized medicine
- 3: Metabolomics applications in personalized medicine
- 4: Metabolomics applications in CAD personalized medicine
- 5: Conclusion and future scope
- Acknowledgment
- Conflict of interest
- Chapter Six: Quantitative EEG biomarkers for epilepsy and their relation to chemical biomarkers
- Abstract
- 1: Introduction
- 2: Chemical biomarkers in epilepsy
- 3: Quantifying qualitative EEG in epilepsy
- 4: EEG frequency biomarkers for epilepsy
- 5: Quantifying the epileptic network
- 6: Entropy measures and nonlinear dynamics in epilepsy
- 7: Application scenarios of quantitative EEG in epilepsy
- 8: Challenges to quantitative EEG
- 9: Future perspectives—The next steps of quantitative EEG into everyday epilepsy patient management
- Acknowledgments
- Index
- No. of pages: 356
- Language: English
- Edition: 1
- Volume: 102
- Published: May 24, 2021
- Imprint: Academic Press
- Hardback ISBN: 9780128246146
- eBook ISBN: 9780323850995
GM
Gregory S. Makowski
Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.